Eversept Partners, LP Vera Therapeutics, Inc. Transaction History
Eversept Partners, LP
- $904 Million
- Q1 2025
A detailed history of Eversept Partners, LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 1,898,804 shares of VERA stock, worth $41.4 Million. This represents 5.04% of its overall portfolio holdings.
Number of Shares
1,898,804
Previous 1,600,015
18.67%
Holding current value
$41.4 Million
Previous $67.7 Million
32.59%
% of portfolio
5.04%
Previous 6.83%
Shares
15 transactions
Others Institutions Holding VERA
# of Institutions
195Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$124 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$104 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$72.8 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$64.6 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$63.7 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $590M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...